These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 7705869)
1. A comparative study of delayed neurotoxicity in hens following repeated administration of organophosphorus compounds. Husain K; Pant SC; Raza SK; Singh R; Das Gupta S Indian J Physiol Pharmacol; 1995 Jan; 39(1):47-50. PubMed ID: 7705869 [TBL] [Abstract][Full Text] [Related]
3. In vivo inhibition of chicken brain acetylcholinesterase and neurotoxic esterase in relation to the delayed neurotoxicity of leptophos and cyanofenphos. Soliman SA; Curley A; Farmer J; Novak R J Environ Pathol Toxicol Oncol; 1986; 7(1-2):211-24. PubMed ID: 2432215 [TBL] [Abstract][Full Text] [Related]
4. Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethylsulfonyl fluoride. Pope CN; Padilla S J Toxicol Environ Health; 1990 Dec; 31(4):261-73. PubMed ID: 2254952 [TBL] [Abstract][Full Text] [Related]
5. Potentiation of organophosphorus compound-induced delayed neurotoxicity (OPIDN) in the central and peripheral nervous system of the adult hen: distribution of axonal lesions. Randall JC; Yano BL; Richardson RJ J Toxicol Environ Health; 1997 Aug; 51(6):571-90. PubMed ID: 9242229 [TBL] [Abstract][Full Text] [Related]
6. Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors. Wu SY; Casida JE Toxicol Appl Pharmacol; 1996 Jul; 139(1):195-202. PubMed ID: 8685903 [TBL] [Abstract][Full Text] [Related]
7. DFP initiated early alterations of PKA/p-CREB pathway and differential persistence of beta-tubulin subtypes in the CNS of hens contributes to OPIDN. Damodaran TV; Gupta RP; Attia MK; Abou-Donia MB Toxicol Appl Pharmacol; 2009 Oct; 240(2):132-42. PubMed ID: 19664648 [TBL] [Abstract][Full Text] [Related]
9. Comparative evolution of mipafox-induced delayed neuropathy in rats and hens. Carboni D; Ehrich M; Dyer K; Jortner BS Neurotoxicology; 1992; 13(4):723-33. PubMed ID: 1302299 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the relative inhibition of acetylcholinesterase and neuropathy target esterase in rats and hens given cholinesterase inhibitors. Ehrich M; Jortner BS; Padilla S Fundam Appl Toxicol; 1995 Jan; 24(1):94-101. PubMed ID: 7713347 [TBL] [Abstract][Full Text] [Related]
11. Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase. Kropp TJ; Richardson RJ J Toxicol Environ Health A; 2003 Jun; 66(12):1145-57. PubMed ID: 12791540 [TBL] [Abstract][Full Text] [Related]
12. The effect of a single oral dose of tri-o-cresyl phosphate on neurotoxic esterase and acetylcholinesterase activities in the central nervous system, erythrocytes and plasma. Barrett DS; Oehme FW Vet Hum Toxicol; 1994 Feb; 36(1):1-4. PubMed ID: 8154093 [TBL] [Abstract][Full Text] [Related]
13. Is delayed neurotoxicity a property of all organophosphorus compounds? A study with a model compound: parathion. Soliman SA; Farmer J; Curley A Toxicology; 1982; 23(4):267-79. PubMed ID: 7123563 [TBL] [Abstract][Full Text] [Related]
14. The correlation between neurotoxic esterase inhibition and mipafox-induced neuropathic damage in rats. Veronesi B; Padilla S; Lyerly D Neurotoxicology; 1986; 7(1):207-15. PubMed ID: 3714122 [TBL] [Abstract][Full Text] [Related]
15. Time course for neurotoxic esterase inhibition in hens given multiple diisopropyl fluorophosphate injections. Sprague GL; Sandvik LL; Bickford AA Neurotoxicology; 1981 Nov; 2(3):523-32. PubMed ID: 7199689 [TBL] [Abstract][Full Text] [Related]
16. Comparative dose-response studies of organophosphorus ester-induced delayed neuropathy in rats and hens administered mipafox. Dyer KR; Jortner BS; Shell LG; Ehrich M Neurotoxicology; 1992; 13(4):745-55. PubMed ID: 1302301 [TBL] [Abstract][Full Text] [Related]